| Name | Title | Contact Details |
|---|
Cornerstone Therapeutics, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Cary, NC. To find more information about Cornerstone Therapeutics, Inc., please visit www.crtx.com
sbifinechemicals is a EDMONTON, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Inspyr Therapeutics, Inc. is a biotechnology company focused on the development and commercialization of promising, new therapeutics. Our work is motivated by a commitment to innovation and helping patients. We combine our powerful insights and rigorous scientific methods to create new treatment options for patients.
DENTSPLY International is a leading manufacturer and distributor of dental and other consumable healthcare products. Our broad global product platform helps dental professionals serve patients` oral health care for a lifetime, from preventive services to tooth replacement. DENTSPLY oral health products range from general dental consumables and laboratory products to products supporting the dental specialty markets of orthodontics, endodontics and implants. Our powerful worldwide dental sales force takes our solutions to market around the globe. Now more than 2,800 members strong, our sales team keeps us close to the dental professionals who rely on our product solutions to serve their patients` complete oral health needs. DENTSPLY’s global consumable healthcare product team provides innovative urological and surgical solutions designed to improve the quality of life for users, caregivers, and practitioners. With a presence in more than 120 countries, patients and practitioners virtually everywhere in the world rely on DENTSPLY to deliver dental and healthcare solutions with a strong focus on quality, innovation, and service.
Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.